Replimune (REPL) Interest & Investment Income (2017 - 2025)

Replimune's (REPL) quarterly Interest & Investment Income came in at $2.8 million in Q4 2025, down 44.6% year-on-year from $5.1 million in Q4 2024, and down 23.0% quarter-over-quarter from $3.7 million in Q3 2025.

Replimune (REPL) Interest & Investment Income (2017 - 2025) Analysis & Trends

Replimune has disclosed Interest & Investment Income across 9 years of filings, most recently posting $2.8 million for Q4 2025.

  • Interest & Investment Income for Q4 2025 came in at $2.8 million, down 44.6% year-over-year; the trailing twelve-month figure through Dec 2025 was $17.1 million (down 17.14% YoY), and the FY2025 annual result was $21.1 million, down 9.57% from the prior year.
  • Interest & Investment Income came in at $2.8 million for Q4 2025 at Replimune, down from $3.7 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $6.2 million in Q2 2023 to a low of $80000.0 in Q3 2021.
  • The 5-year median for Interest & Investment Income is $4.2 million (2024), against an average of $3.3 million.
  • Across the five-year window, Interest & Investment Income slumped 84.68% in 2021 and jumped 4385.5% in 2023, its largest moves.
  • Replimune's Interest & Investment Income stood at $87000.0 in 2021, then jumped by 2974.71% to $2.7 million in 2022, then soared by 112.56% to $5.7 million in 2023, then declined by 9.66% to $5.1 million in 2024, then slumped by 44.6% to $2.8 million in 2025.
  • The last three Interest & Investment Income figures came in at $2.8 million (Q4 2025), $3.7 million (Q3 2025), and $4.7 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 597,319.59
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 40.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - 305,000.00
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 103,341.00
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 114.80 Mn
9 Abivax 91.71 Bn 91.71 Bn - -14.79 Mn
10 Replimune 780.01 Mn 510.88 Mn - 2.85 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.85 Mn
Sep 30, 2025 3.70 Mn
Jun 30, 2025 4.71 Mn
Mar 31, 2025 5.88 Mn
Dec 31, 2024 5.14 Mn
Sep 30, 2024 5.39 Mn
Jun 30, 2024 4.71 Mn
Mar 31, 2024 5.43 Mn
Dec 31, 2023 5.69 Mn
Sep 30, 2023 6.05 Mn
Jun 30, 2023 6.19 Mn
Mar 31, 2023 5.88 Mn
Dec 31, 2022 2.68 Mn
Sep 30, 2022 1.11 Mn
Jun 30, 2022 343,000.00
Mar 31, 2022 131,000.00
Dec 31, 2021 87,000.00
Sep 30, 2021 80,000.00
Jun 30, 2021 92,000.00
Mar 31, 2021 95,000.00